Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Existing research supports metabolic syndrome link to cardiovascular disease

23.01.2007
Meta-analysis provides evidence that cardiovascular risk is greater with metabolic syndrome than with individual factors alone

For years cardiologists and other specialists have disagreed over the condition known as metabolic syndrome, a complex confluence of factors such as abdominal obesity, low HDL, or "good" cholesterol and hypertension.

Physicians and academics have disputed the syndrome's existence and whether it predicts cardiovascular danger. The central question of this debate has been whether the gathering of these conditions in a single person conveys a risk of heart disease greater than that conveyed by each of the components. In other words, is the whole greater than the sum of its parts? The current best evidence now shows that metabolic syndrome represents an increased risk of cardiovascular disease and death, especially in women, according to a new study in the January 30, 2007, issue of the Journal of the American College of Cardiology.

The research was conducted at the Mayo Clinic College of Medicine in Rochester, Minn. Lead researcher Apoor S. Gami, M.D., assistant professor of medicine in the division of cardiovascular diseases and internal medicine at the college, said the goal of the study was to collate and compare all the differing studies on metabolic syndrome and the risk of cardiovascular disease,.

"What was fascinating to us was the fact that all this controversy in the field existed despite the prior publication and continuing publication of countless studies on the topic," said Dr. Gami. "We decided to use the tools of meta-analysis to best assimilate the available data and to identify relationships that might not have been clear in individual studies. In this way we could highlight important associations regarding metabolic syndrome and cardiovascular disease."

Metabolic syndrome is a constellation of conditions, each of which individually is known to increase the risk of heart disease. Depending on the source, metabolic syndrome can include hyperglycemia, abdominal obesity, low HDL cholesterol (good cholesterol), increased triglycerides, dyslipidemia and hypertension. The condition has been attributed to the combined effects of a sedentary lifestyle, poor diet and genetic factors.

This meta-analysis provides evidence that the constellation of findings do constitute a syndrome when occurring in a single patient. It also lends some suggestive support that truncal obesity may be basic to the occurrence of other conditions (perhaps through insulin resistance) which markedly increase risk, particularly in females.

Over the years numerous agencies and individual researchers have attempted to either discount or define the syndrome. In 2005, the American Diabetes Association and their European counterpart raised many uncertainties regarding the syndrome, including its effect on cardiovascular disease risk and whether the syndrome itself was worthy of a diagnosis. In the same year, the American Heart Association and the National Heart, Lung, and Blood Institute issued a report stating that the aggregation of the factors making metabolic syndrome increases heart risk and should be aggressively targeted for medical intervention.

"There had not yet been a systematic qualitative or quantitative approach to understanding the data as a whole," Dr. Gami said. "Our review of the best available evidence showed that in over 37 studies published since 1998, which included 43 groups of patients and over 170,000 individuals, metabolic syndrome, no matter how it is specifically defined, does increase the risk of new cardiovascular disease and death, with even greater risk in women."

The researchers analyzed 4,198 publications to find 37 original and relevant articles published since 1998. The studies were all longitudinal studies assessing cardiovascular events and/or death in people with three or more coronary risk factors, regardless of whether they were labeled metabolic syndrome. The researchers used meta-analysis to examine the results qualitatively and quantitatively.

"The significance of this finding is that patients with metabolic syndrome need to be identified and aggressively targeted for interventions in order to prevent cardiovascular disease and premature death," said Dr. Gami. "In addition, caregivers should pursue preventative interventions aggressively with women. Although women generally have lower cardiovascular risk than men, it appears this is not the case when metabolic syndrome is present."

Michaela Diamant, M.D., Ph.D., an associate professor of medicine at the Diabetes Center of the VU University Medical Center in The Netherlands, did not participate in the study but said it raises several questions.

"This research summarizes and confirms earlier data, but it is important to be careful with statements regarding the value of the metabolic syndrome," said Dr. Diamant. "It is a shame that doctors and the public need a tool such as a diagnosis of metabolic syndrome to become aware of the risk of lifestyle-related obesity, dyslipidemia and high blood pressure. If anything, the attention paid to this syndrome should increase the awareness of doctors and the public that an abdominally obese individual may have an increased risk.

"The controversy has not ended," Dr. Diamant continued. "Questions still exist: Does the metabolic syndrome fulfill the criteria of a syndrome? Does it truly predict a higher risk than the separate components? What is the basis for the cut-off points for the various components? Why do we use the components that are now in the definition, and do they exclude patients that truly need care? We should still focus on improving the treatment of the individual components that may make up metabolic syndrome, as we still don't succeed in treating our patients with these abnormalities completely and adequately."

Dr. Gami and his team recommend that their study initiate a series of new scientific investigations focused on interventions that target metabolic syndrome. Dr. Diamant agrees that research is needed, on young people in particular, but with a different focus.

"Research is needed to test the current definitions of metabolic syndrome and improve them, finding a rationale for their existence," said Dr. Diamant. "If people need the metabolic syndrome to remind them of the fact that an obviously overweight or obese individual with a bad lifestyle is at increased risk of cardiovascular danger, then they should use it. But far more work should be done to understand the mechanisms of the syndrome and to define it more thoroughly."

Amy Murphy | EurekAlert!
Further information:
http://www.acc.org

More articles from Health and Medicine:

nachricht Study suggests possible new target for treating and preventing Alzheimer's
02.12.2016 | Oregon Health & Science University

nachricht The first analysis of Ewing's sarcoma methyloma opens doors to new treatments
01.12.2016 | IDIBELL-Bellvitge Biomedical Research Institute

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Novel silicon etching technique crafts 3-D gradient refractive index micro-optics

A multi-institutional research collaboration has created a novel approach for fabricating three-dimensional micro-optics through the shape-defined formation of porous silicon (PSi), with broad impacts in integrated optoelectronics, imaging, and photovoltaics.

Working with colleagues at Stanford and The Dow Chemical Company, researchers at the University of Illinois at Urbana-Champaign fabricated 3-D birefringent...

Im Focus: Quantum Particles Form Droplets

In experiments with magnetic atoms conducted at extremely low temperatures, scientists have demonstrated a unique phase of matter: The atoms form a new type of quantum liquid or quantum droplet state. These so called quantum droplets may preserve their form in absence of external confinement because of quantum effects. The joint team of experimental physicists from Innsbruck and theoretical physicists from Hannover report on their findings in the journal Physical Review X.

“Our Quantum droplets are in the gas phase but they still drop like a rock,” explains experimental physicist Francesca Ferlaino when talking about the...

Im Focus: MADMAX: Max Planck Institute for Physics takes up axion research

The Max Planck Institute for Physics (MPP) is opening up a new research field. A workshop from November 21 - 22, 2016 will mark the start of activities for an innovative axion experiment. Axions are still only purely hypothetical particles. Their detection could solve two fundamental problems in particle physics: What dark matter consists of and why it has not yet been possible to directly observe a CP violation for the strong interaction.

The “MADMAX” project is the MPP’s commitment to axion research. Axions are so far only a theoretical prediction and are difficult to detect: on the one hand,...

Im Focus: Molecules change shape when wet

Broadband rotational spectroscopy unravels structural reshaping of isolated molecules in the gas phase to accommodate water

In two recent publications in the Journal of Chemical Physics and in the Journal of Physical Chemistry Letters, researchers around Melanie Schnell from the Max...

Im Focus: Fraunhofer ISE Develops Highly Compact, High Frequency DC/DC Converter for Aviation

The efficiency of power electronic systems is not solely dependent on electrical efficiency but also on weight, for example, in mobile systems. When the weight of relevant components and devices in airplanes, for instance, is reduced, fuel savings can be achieved and correspondingly greenhouse gas emissions decreased. New materials and components based on gallium nitride (GaN) can help to reduce weight and increase the efficiency. With these new materials, power electronic switches can be operated at higher switching frequency, resulting in higher power density and lower material costs.

Researchers at the Fraunhofer Institute for Solar Energy Systems ISE together with partners have investigated how these materials can be used to make power...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

ICTM Conference 2017: Production technology for turbomachine manufacturing of the future

16.11.2016 | Event News

Innovation Day Laser Technology – Laser Additive Manufacturing

01.11.2016 | Event News

#IC2S2: When Social Science meets Computer Science - GESIS will host the IC2S2 conference 2017

14.10.2016 | Event News

 
Latest News

UTSA study describes new minimally invasive device to treat cancer and other illnesses

02.12.2016 | Medical Engineering

Plasma-zapping process could yield trans fat-free soybean oil product

02.12.2016 | Agricultural and Forestry Science

What do Netflix, Google and planetary systems have in common?

02.12.2016 | Physics and Astronomy

VideoLinks
B2B-VideoLinks
More VideoLinks >>>